Moreover, WT mice, given a neutralizing IL-21R/Fc fusion protein, exhibit an amelioration of experimental colitis as compared to control mice (29); however, this was not confirmed by our experiments, which could be due to strain-specific alterations or due to the pharmacologic properties of the molecule. The gene discussed is IL21R; the disease is colitis.